MLSS vs. INGN, LAKE, CLGN, APT, NTRB, COCH, RBOT, LFWD, POAI, and HSCS
Should you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Alpha Pro Tech (APT), Nutriband (NTRB), Envoy Medical (COCH), Vicarious Surgical (RBOT), ReWalk Robotics (LFWD), Predictive Oncology (POAI), and Heart Test Laboratories (HSCS). These companies are all part of the "surgical appliances & supplies" industry.
Milestone Scientific (NYSE:MLSS) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.
Inogen has a consensus target price of $7.00, suggesting a potential downside of 15.66%. Given Inogen's higher probable upside, analysts plainly believe Inogen is more favorable than Milestone Scientific.
Inogen received 386 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 70.44% of users gave Inogen an outperform vote while only 0.00% of users gave Milestone Scientific an outperform vote.
In the previous week, Inogen had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for Inogen and 0 mentions for Milestone Scientific. Inogen's average media sentiment score of 1.43 beat Milestone Scientific's score of 0.00 indicating that Inogen is being referred to more favorably in the news media.
5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 25.2% of Milestone Scientific shares are owned by company insiders. Comparatively, 1.0% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Milestone Scientific has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
Inogen has a net margin of -30.07% compared to Milestone Scientific's net margin of -74.50%. Inogen's return on equity of -42.87% beat Milestone Scientific's return on equity.
Milestone Scientific has higher earnings, but lower revenue than Inogen. Milestone Scientific is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.
Summary
Inogen beats Milestone Scientific on 13 of the 17 factors compared between the two stocks.
Get Milestone Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Milestone Scientific Competitors List
Related Companies and Tools
